Type and hit ENTER

Footer – After

Shout WordPress Theme by Pirenko.

Made in Portugal. With Love.

New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases

June 3, 2019
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in …
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting

November 26, 2018
The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed …
ProAxsis assays selected for inclusion in major new ERS-funded study

September 20, 2018
ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement …

ProAxsis

RT @pharmacyatQUB: We'll be celebrating our students' successes this evening at our Undergraduate Awards Ceremony. Thanks to our sponsors:…

9 hours ago

RT @drAnand_Shah_: @Shoemelia presenting evidence for point of care neutrophil elastase use in #bronchiectasis #ERSCongress2019 https://t.c…

12 days ago

RT @BlfResearch: Further studies are needed to assess how widely NEATstik could be used in clinical practice, but it can help tackle the mi…

12 days ago

RT @BlfResearch: What does it mean for patients? At the moment, it takes several days to carry out tests to confirm a chest infection. This…

12 days ago

Footer - After | ProAxsis